Wunderlich Capital Managemnt’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-12,574
Closed -$890K 93
2017
Q2
$890K Sell
12,574
-29
-0.2% -$1.93K 0.67% 73
2017
Q1
$856K Sell
12,603
-75
-0.6% -$5.27K 0.67% 71
2016
Q4
$908K Sell
12,678
-1,104
-8% -$82.1K 0.74% 68
2016
Q3
$1.09M Sell
13,782
-1,652
-11% -$134K 0.87% 63
2016
Q2
$1.29M Buy
15,434
+581
+4% +$51.6K 1.09% 56
2016
Q1
$1.36M Buy
14,853
+192
+1% +$17.3K 1.17% 42
2015
Q4
$1.48M Buy
14,661
+292
+2% +$30.4K 1.27% 25
2015
Q3
$1.41M Sell
14,369
-169
-1% -$18.8K 1.3% 22
2015
Q2
$1.7M Sell
14,538
-83
-0.6% -$9.07K 1.65% 10
2015
Q1
$1.43M Sell
14,621
-32
-0.2% -$3.25K 1.29% 21
2014
Q4
$1.38M Buy
14,653
+566
+4% +$58.5K 1.17% 35
2014
Q3
$1.49M Sell
14,087
-121
-0.9% -$11.8K 1.34% 15
2014
Q2
$1.18M Buy
+14,208
New +$1.11M 1.08% 53

Other funds holding GILD

Wunderlich Capital Managemnt's GILD Position: Q3 2017 in Review

Wunderlich Capital Managemnt sold out of Gilead Sciences (GILD) in Q3 2017, closing a stake of 12,574 shares — an estimated $890K sold.

Wunderlich Capital Managemnt first reported a position in GILD in Q2 2014 and held it in 13 quarters. The position peaked at $1.7M in Q2 2015. 1,504 funds tracked by Wall St. Rank hold GILD as of Q3 2017.

  • Wunderlich Capital Managemnt reported no remaining Gilead Sciences position as of Q3 2017 after selling out during the quarter.
  • Wunderlich Capital Managemnt sold 12,574 Gilead Sciences shares in Q3 2017, an estimated $890K.
  • Wunderlich Capital Managemnt first reported a position in Gilead Sciences in Q2 2014 and held it in 13 quarters.
  • Wunderlich Capital Managemnt's Gilead Sciences position peaked at $1.7M in Q2 2015.
  • 1,504 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2017.

Based on Wunderlich Capital Managemnt's 13F filing for Q3 2017, filed 15 Nov 2017.